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Abstract: The prevalence of childhood allergic diseases, such as
allergic asthma, allergic rhinitis, and atopic dermatitis, has increased
exponentially. In Singapore, the prevalence of asthma at all ages
exceeds 20%, and around 50% of Singaporean children show features
of an underlying allergy. The exact environmental causes for the
increase of allergic diseases have not yet been identiﬁed, but most
researchers agree that a decreased bacterial load in young children
may be one of the reasons for the increase. However, the causes of
allergy are multiple, and the development of an allergic disease is the
result of complex interactions between genetic constitution and
environmental factors. In this review article, different aspects of
allergic sensitization are covered, including prenatal and postnatal
sensitization. The phenomenon of the Ballergic march[ (switching
from one clinical expression of allergy to another) and its underlying
mechanisms are discussed. The last part of this review article is on
prevention and treatment of allergic diseases, including the role of
bacterial products (probiotics, prebiotics, and synbiotics) and the role
of immunotherapy, including sublingual immunotherapy.
Key Words: review, allergy, children, allergic march, probiotics,
immunotherapy
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In the past 3 decades, the prevalence of childhood allergicdiseases, such as allergic asthma, allergic rhinitis, and atopic
dermatitis has increased exponentially. In Singapore, the
prevalence of asthma at all ages exceeds 20%, and around
50% of Singaporean children show features of an underlying
allergy.1Y3 It is commonly accepted that a child without allergic
parents may have up to a 20% risk of developing allergy. If the
father (but not the mother) is allergic, the risk is 40%, whereas
if the mother (but not he father) is allergic, the risk is 50%.
When both parents are known to be allergic, the risk to the
child of developing allergy can be as high as 90%. The exact
environmental causes for the increase of allergic diseases have
not yet been identiﬁed, but most researchers agree that a close
relationship with a Bwestern lifestyle,[ one that results in a
decreased bacterial load (eg, altered commensal ﬂora) in young
children, may be one of the reasons for the increase. This is
summarized in the so-called hygiene hypothesis and has been
conﬁrmed in studies showing that early contact with bacterial
products (eg, from living on a farm, developing infections,
attending day care centers) confers a protective effect on the
potential development of subsequent allergy.4,5 In contrast,
factors that have been associated with the increased prevalence
of allergic diseases include indoor and outdoor pollution,
various viral infections (such as infections with respiratory
syncytial virus), and an increased use of medication (such as
antibiotics and paracetamol) early in life.6,7 A study from
Taiwan has shown that fungi on the walls of the house
(adjusted odds ratio [aOR], 2.14; 95% conﬁdence interval,
1.41Y3.22) increased the risk of early infantile atopic
dermatitis. Fungi might have a role in sensitization, particu-
larly in humid climates where impacts on allergy may be felt at
an early infant stage.8
PRENATAL SENSITIZATION
The cause of allergy is multifactorial, and the develop-
ment of an allergic disease is the result of complex interactions
between genetic constitution and environmental factors.
Genetic constitution is important, as it is only in genetically
predisposed individuals that the environment is able to trigger
symptoms of allergy.9 In children of parents with asthma, the
rate of observed food allergy may be 4 times higher than in the
general population.10
The existence of prenatal sensitization to allergens is
still a matter of debate. In some studies, it has been suggested
that allergic immune responses start during fetal life, and that
the fetus already responds to allergens from week 20 of
pregnancy.11 Fetal exposure to different allergens has been
demonstrated from the presence of houseYdust mite allergens
in amniotic ﬂuid and an active transplacental transport
mechanism of different allergens (food allergens and
inhalant allergens). The important allergens that have been
suggested to cause prenatal sensitization include food
allergens (peanuts, eggs, and cow_s milk) and inhaled
allergens, such as houseYdust mites.12,13 However, from
other studies, it seems that cord blood T cells responding to
allergens are not memory cells but immature thymic
emigrants interacting nonspeciﬁcally with allergens, and
that these immune reactions are unrelated to subsequent
development of allergen-speciﬁc T helper cells 2 (Th2)
memory or immunoglobulin E (IgE).14
Apart from genetic constitution, nutritional, immunolo-
gic, and environmental factors acting during pregnancy all
play a role in determining whether a child will be born with the
propensity to develop allergic sensitization and subsequent
allergic disease.
POSTNATAL BEGINNINGS
One of the major environmental risk factors that
interact with genetic predisposition in the development of
allergy is inhaled allergens. However, exposure to certain
foreign food proteins, like those found in cow_s milk (5%), in
REVIEW ARTICLE
WAO Journal & April 2008 57
Received for publication February 14, 2008; accepted February 14, 2008.
From the Department of Pediatrics, National University Singapore, Singapore.
Reprints: Hugo P. Van Bever, MD, PhD, Department of Paediatrics, National
University Hospital, 5 Lower Kent Ridge Rd, 119074 Singapore,
Singapore. E-mail: paevbhps@nus.edu.sg
Copyright * 2008 by World Allergy Organization
early life can also contribute to allergy development in
genetically predisposed individuals. In unmodiﬁed cow_s
milk, there are more than 32 types of proteins with potential
to trigger food allergy.15 Similarly, plant proteins, like soy
protein, also possess the potential to spark off food allergy.
Infants, 15% to 50% of them, who are allergic to cow_s milk
are also allergic to soya milk.16 Although any food can cause
food allergy, the more potent ones are eggs, milk, peanuts,
tree nuts (eg, almond, walnut, cashew, hazelnut, etc), ﬁsh,
shellﬁsh, and soya bean.17 Peanut allergy, which affects
approximately 0.6% of the general population in the United
States, is the most common cause of fatal food-induced
anaphylaxis, especially in adolescents with asthma.10 In
Singapore, peanut allergy is less common. The state of the
digestive tract and age of the child when ﬁrst exposed to the
offensive food are equally important. Whereas young
children and infants may present with eczema, older children
can often present with swelling and hives. Sensitivity to most
food allergens, such as milk, wheat, and egg, tends to resolve
in late childhood, but allergies to peanut, tree nuts, and
seafood are likely to be lifelong. Whereas food allergy (egg,
cow_s milk) is the main type of reaction during the ﬁrst year
of life, allergy to inhaled allergens (houseYdust mite, pets)
seldom occurs during infancy (although sensitization could
already have begun). In young children, eczema and chronic
gastroenteritis are usually the ﬁrst manifestations of allergy,
whereas in older subjects, allergy manifests itself more often
as a chronic or recurrent respiratory disease (asthma and/or
allergic rhinitis).
THE ALLERGIC MARCH
The phenomenon of switching from 1 clinical expres-
sion of allergy to another in progressive stages of life is called
Bthe allergic march.[18 Several studies have demonstrated
this phenomenon (also known as the atopic march).19 In the
United Kingdom, Rhodes and colleagues20 studied 100
infants from atopic families over a 22-year period. The
prevalence of atopic eczema reached a peak in 20% of
children at 1 year of age and then declined to just below 5%
by the end of the study. The prevalence of allergic rhinitis
increased from 3% to 15% during the study period. Parent-
reported wheezing of the study group increased from 5%
during the ﬁrst year of life to 40% at 22 years of age.
Sensitization to allergens as determined by skin-prick tests
(SPTs) to 6 common allergens (Dermatophagoides ptero-
nyssinus, mixed grasses, dog, cat, egg, and milk) increased to
a peak of 36% at 22 years of age. The major risk factor for the
development of adult asthma from the study was the early
sensitization to either food in the ﬁrst year of life or
aeroallergens in the ﬁrst 2 years of life. A German study, the
large Multicentric Atopy Study, demonstrated the features of
the allergic march in 1314 children during a 7-year study
period.21 A high-risk group comprising 38% of the children
was identiﬁed, where at least 2 family members had atopic
diseases or the child had a cord-blood IgE greater than 0.9
kU/L at birth. In this group, 69% of infants who had
developed atopic eczema by 3 months of age were sensitized
to aeroallergens by the age of 5 years. The rate of
aeroallergen sensitization increased to 77% in all high-risk
children. At 5 years, 50% of children with early atopic
eczema and a positive family history of allergy had developed
asthma or rhinitis compared with only 12% of children
without eczema or a positive family history of allergy.
In the search for a link between atopic dermatitis and
airway allergy, Dohi and colleagues22 studied 8 patients with
bronchial asthma without atopic dermatitis and 8 patients with
atopic dermatitis without bronchial asthma for houseYdust
mite sensitization. The atopic dermatitis patients had a
signiﬁcantly greater concentration of IgE (P G 0.01) and
antimite IgE antibody (P G 0.05) than bronchial asthma
patients. Both groups had inhalation challenges to acetylcho-
line (nonspeciﬁc bronchodilator) and to houseYdust mites
(immunologically speciﬁc stimulus). After allergen challenge,
all patients showed an immediate asthmatic response, although
it was noted that the mite extract concentration required to
induce the response was signiﬁcantly greater (P G 0.01) in the
atopic dermatitis patients compared with the bronchial asthma
patients. A late asthmatic response was also observed in 6 out
of 8 bronchial asthma patients compared with none in the
atopic dermatitis group, highlighting that a difference in the
bronchial reactivity to the allergen between the groups can
contribute to a difference in the course of clinical symptoms of
asthma. The results suggest that the airways of atopic
dermatitis patients are less reactive to a speciﬁc mite allergen
than bronchial asthma patients despite greater concentrations
of antimite IgE antibody.
Further evidence that skin sensitization is linked to
airway sensitization was demonstrated when Brinkman and
colleagues23 evaluated the degree of bronchial responsive-
ness to methacholine in 8 atopic dermatitis patients with
allergic asthma and 8 atopic dermatitis patients without
allergic asthma followed up with a study of bronchial and
cutaneous responses after allergen inhalation challenge. The
mean provocative concentration of methacholine causing the
same fall in forced expiratory volume in 1 second (FEV1) for
both groups was signiﬁcantly higher in the group without
allergic asthma. After allergen inhalation challenge, all 8
allergic asthma patients showed early and late asthmatic
responses, whereas only 4 patients in the group without
allergic asthma showed early asthmatic responses. Although
both groups showed cutaneous response after allergen
inhalation challenge, the increase in the cutaneous response
24 hours after allergen inhalation challenge was noted to be
signiﬁcantly higher (P = 0.016) in the group with allergic
asthma. The results show that allergen inhalation can cause a
ﬂare-up of skin lesions in atopic dermatitis patients, and this
ﬂare-up is likely to be more prominent in those atopic
dermatitis patients who already have IgE-mediated allergic
inﬂammation in the lung. It is generally accepted that the
increased prevalence of allergic diseases during recent years
is caused by a disturbed balance between Th1 and Th2,
leading to a greater expression of Th2 features from the
secretion of various cytokines that can include interleukin 4
(IL-4), IL-5, IL-6, IL-10, IL-13, and IL-14. These cytokines
are able to induce IgE production and activate eosinophils
leading to allergic inﬂammation. The exact reasons for the
skewing of the Th1-Th2 balance toward the Th2 proﬁle
in allergic individuals are unknown, although decreased
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postnatal microbial stimulation can result in an increased
possibility of ongoing postnatal Th2 reactions.
It is important to address the lead-up to the eventuality
of allergic asthma in these children because once asthma sets
in, these children (and their parents) are often faced with the
signiﬁcant problems of:
& Trigger avoidance,
& Adherence to anti-inﬂammatory medication, and
& Stigma in the social context: the challenge for children of
not wanting to show that they have asthma. Children may
want to hide the fact that they have to take medications and
have to avoid trigger factors and become excluded from
normal social life.
DIAGNOSING ALLERGY EARLY
A number of early markers have been identiﬁed for
atopy, indicating the propensity for the development of the
allergic march:
& Elevated cord-blood IgE levels,24
& Positive SPTs to egg or houseYdust mite in the ﬁrst year of
life, and
& Detection of speciﬁc IgE to common foods and inhalant
allergens in early infancy.
The use of in vitro panels has proven to be effective in
ruling out allergy in children. With sensitivities and negative
predictive values exceeding 90%, in vitro panels can provide
important information to pediatricians on early diagnosis.25
The SPT is still considered to be the criterion standard
in diagnosing allergy in children of all ages and in adults, but
is equally reliable in determining speciﬁc IgE in serum. The
SPT is prone to human error, and problems with proin-
ﬂammatory impurities in some SPT allergen preparations can
cause potentially false-positive results. Therefore, the
accuracy of SPT depends on the skill and experience of the
person performing the SPT. Although the sensitivity and
speciﬁcity of SPT are comparable to those of serum IgE, the
SPT offers a number of advantages: faster results (within 30
minutes) and is cheaper than in vitro IgE tests. The SPT can
be performed at all ages (even in newborns), is not painful,
and is very safe (extremely low risk for any side effect).
According to age group, standardized panels of allergens are
used based on prevalence of the most common allergens
causing allergic disease in Singaporean children. In young
children, SPTs are more focused on food allergens (cow_s
milk, egg), whereas in older children with allergies, inhalant
allergens, such as houseYdust mites, are used. The SPT can
be performed on an outpatient basis. In the future, more
sophisticated antibody assay methodologies (such as emer-
ging protein array technology) might become standard of
diagnosing allergy.
TREATMENT OPTIONS
Because allergic diseases are mainly genetically
determined, there are no speciﬁc cures. However, recent
studies on immunotherapy (ie, repeated administrations of
well-deﬁned doses of allergen) have shown that this
treatment is able to result in sustained desensitization of
the patient, even after having stopped the treatment.26
Immunotherapy, especially the use of sublingual immu-
notherapy, may be promising for the future, although this
type of treatment will only be effective in certain groups of
monosensitized patients with rhinitis or asthma and not in all
children with allergy (such as children with food allergy or
severe eczema).27
In recent years, the ﬁrst studies with anti-IgE (omalizu-
mab) gave promising results, and in 1 study, the combination of
anti-IgE and speciﬁc immunotherapy was very effective in
children with seasonal allergic rhinitis.28 In most children,
however, treatment of allergic diseases mainly constitutes
allergen avoidance and symptomatic treatment using corticos-
teroids, antihistamines, and different antiasthmatic medications.
STRATEGIES FOR PREVENTION
Prevention of allergic diseases and symptoms remains
the most attractive approach to date in the battle to halt the
allergic march. Some research exists to suggest a beneﬁt of
maternal supplementation with omega-3 unsaturated fatty
acids (from ﬁsh oil) and selenium before delivery.29,30 Other
studies, however, suggest no such effect, and the current
overall evidence implies that maternal dietary interventions
may not have any preventive effect on the development of
allergy. Early prevention often relies on the prevention of
sensitization in healthy infants. Such measures include
avoidance of early allergen contacts (foods and inhalants)
and avoidance of pollution (mainly cigarette smoke). The
effect of early allergen avoidance is still a matter of intense
debate, and it is still not clear whether primary avoidance of
allergens has any beneﬁcial effect or, in contrast, may facilitate
allergic sensitization. In a limited number of studies, early
avoidance of houseYdust mite and pollen has been shown to
reduce the occurrence of subsequent allergic diseases.
However, in other studies, no effect was observed. In contrast,
high concentrations of cat allergen early on seem to induce
tolerance.7,31 As with every infant, breast-feeding is generally
considered as ﬁrst choice for atopic infants, although its
potency to inhibit the development of allergy is still unclear.
However, most studies agree that, at least, breast-feeding
seems to delay or prevent the occurrence of allergy, especially
cow_s milk allergy.32 Hypoallergenic formulas have an
inhibitory effect on the development of cow_s milk allergy.
Using an extensively hydrolyzed casein formula has been
shown to be of beneﬁt in reducing food allergy and atopic
eczema.33
Infants with atopic dermatitis should be a target group
for the prevention of asthma. The late introduction (older than
6 months) of solid foods also seems to be advisable in atopic
infants, whereas administration of eggs should be avoided in
infants with moderate to severe atopic dermatitis.34
At this time, a limited amount of data is available
concerning the preventive effect of medication on the
development of allergic diseases. In a limited number of
studies, the early administration of ketotifen in infants with
eczema was able to prevent the occurrence of asthma. In a
separate study, the same drug inhibited the occurrence
of asthma in high-risk symptom-free infants. Iikura and
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colleagues35 treated 121 children with atopic eczema (aged
1-36 months) with either ketotifen or placebo before the
onset of asthma. After 1 year of study, signiﬁcantly fewer
patients in the ketotifen group had developed asthma
compared with the placebo group.
More recently, the Early Treatment of the Atopic Child
Study involving 795 European children found that cetirizine,
administered for 18 months, was able to delay or prevent the
development of asthma in young children with atopic eczema
and who were allergic to houseYdust mite (51% placebo vs
28.6% cetirizine developed asthma) and/or grass pollen (58%
placebo vs 27.8% cetirizine developed asthma).36,37 How-
ever, in a second large study on levocetirizine known as the
Early Prevention of Asthma in Atopic Children Study, such
results were not conﬁrmable. The Early Prevention of
Asthma in Atopic Children Study and follow-up examined
the role of levocetirizine in delaying the allergic march. This
was a prospective, randomized, double-blind, parallel group,
and placebo-controlled study that enrolled 2500 children
aged 1 to 2 years in Europe, South Africa, and Australia. The
children had atopic eczema and a family history of atopy. The
treatment duration was prolonged to 3 years in total, and
speciﬁc IgE levels were measured at baseline and at regular
intervals throughout the study period. By the end, 40% of the
infants had developed asthma and results showed that
children with early sensitization to egg, milk, cat, grass, or
houseYdust mite had an increased risk of developing asthma.
The study showed no signiﬁcant difference between the
levocetirizine and placebo-treated groups in the development
of asthma. The role of prebiotics, synbiotics, and probiotics
remains unclear, and more studies are needed before general
recommendations can be given. Prebiotics are nondigestible
fermentable oligosaccharides that stimulate the growth of
Biﬁdobacterium and Lactobacillus species.38 Altering the
intake of foods containing these products can directly
inﬂuence the composition and activity of intestinal micro-
biota, and this could explain some of the protective effects of
grains and cereals that have been observed in epidemiolo-
gical studies.39 There remains, however, very little evidence
of efﬁcacy in the use of such therapy. Probiotics are live
microbial food supplements that are believed to beneﬁcially
and safely alter the intestinal microbial balance.38 Synbiotics
are a combination of prebiotics and probiotics. The
gastrointestinal tract functions as a barrier against antigens
from microorganisms and food, and speciﬁc strains of
healthy gut microbiota may aid in regulating the secretion
of inﬂammatory mediators and in directing immune system
development during the period of life when the risk of
allergic disease is very high. From studying mice, at least
some of the anti-inﬂammatory effects seem to be mediated
through toll-like receptor 9 (TLR9) and possibly TLR2 and
TLR4 expressed on enterocytes.40 Intestinal microbiota also
promotes enterocyte production of tumor necrosis factor-A
and prostaglandin E2, which promote the development of
tolerogenic dendritic cells.41
The basis for using probiotics in allergic disease stems
from several observations38:
& Epidemiological links between less exposure to microbes
and rising incidence of allergy
& Intestinal microbiotaVlargest source of microbial exposure
in early immune development
& Intestinal microbiota seems essential for development of
oral tolerance
& Changing patterns of microbiota with progressive
westernization
& Differences in perinatal colonization in children who go on
to develop allergic disease
& Perinatal probiotic use associated with anti-inﬂammatory
immunomodulatory effects
& Presymptomatic immune dysregulation in infants and
newborns predisposed to allergy
& Initial studies with probiotics suggested promise in preven-
tion and early treatment
A study that looked at allergy development and
intestinal ﬂora during the ﬁrst year of life found that infants
who developed allergies often did not have signiﬁcant levels of
enterococci colonization during the ﬁrst month after birth
(72% vs 96% in healthy infants). In addition, infants with
allergies were also less apt to be colonized with biﬁdobacteria
during their ﬁrst year (17%Y39% vs 42%Y69% in healthy
infants). It seems that early administration of probiotics
(starting during pregnancy), in combination with breast-
feeding, is able to reduce the occurrence of eczema.42
Lactobacillus, given during pregnancy and to infants for 6
months may offer protective beneﬁts against atopic dermatitis
for the ﬁrst 2 years of life.28,29 The beneﬁcial effects of
probiotics may, however, be limited by species. In 1 study,
Lactobacillus acidophilus failed to show any reduction in
allergic disease, despite changes in colonization.43 A recent
study showed that Lactobacillus reuteri and Lactobacillus
casei, but not Lactobacillus plantarum, primed monocyte-
derived dendritic cells to drive the development of regulatory
T cells (more Th1).44 Further studies have pointed to
beneﬁcial effects with species that include Lactobacillus
GorbachGoldin, Lactobacillus rhamnosus, and Lactobacillus
fermentum, along with Biﬁdobacterium lactis. One study
showed that a combination of strains and prebiotic galacto-
oligossaccharides led to a reduction in atopic eczema, but had
no effect on sensitization or other allergic disease.39 Of note,
however, is that most of these studies either had small numbers
and/or infants and children with mild disease less likely to
embark on the allergic march.38 In 1 study on L. Gorbach
Goldin, the beneﬁcial effects were only observed in children
with evidence of allergic sensitization and not in children with
atopic dermatitis but no sensitization in those who received the
same probiotics. This ﬁnding highlights the heterogeneity of
atopic dermatitis and the fact that the pattern of the disease can
signiﬁcantly affect the effect of supposedly beneﬁcial
probiotics. Also of note is the lack of effect of such probiotics
in older individuals with asthma and allergic rhinitis,
suggesting that any beneﬁcial effects may be conﬁned to
early life before allergic disease becomes established. Despite
a sound theoretical basis for anticipating beneﬁts, there are
insufﬁcient data to recommend probiotics as a part of standard
therapy in any allergic condition.38 Furthermore, despite
several studies showing beneﬁt in prevention of atopic
eczema, other studies fail to support this. Strains used are
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also important as the term probiotic is also often used loosely
to include bacterial strains with little documented immuno-
modulatory capacity or controlled studies to support claims. It
is unlikely that supplementation with a single probiotic strain
is sufﬁcient to have a major inﬂuence on the diversity of
intestinal microbiota. The complex interactions between gut
bacteria and host encourage an orientation toward altering
dietary substrates as with prebiotics in the hope that this will
have a more global effect on gut microbiota.
CONCLUSIONS
Allergic diseases have now become the most common
group of diseases among children, affecting up to 50% of
children in the Singaporean population. Treatment is mainly
based on preventing and/or controlling symptoms. New
promising treatments have become available, such as the
administration of sublingual immunotherapy. In the future, it is
anticipated that therapies that modify the severity of atopic
eczema in infants and young children will decrease the risk for
the eventual development of asthma and thus prevent the
consequences of the allergic march. Intensive research is still
required before a potential cure for all allergic children may
eventually be developed.
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